Skip to main content Skip to section navigation Skip to footer
Immunovant, Inc.
  • Home
  • About Us
    • Our Leadership
  • Our Science
    • Introduction to FcRn
    • Pipeline & Therapeutic Areas
  • Patients & Caregivers
    • Our Commitment
    • Therapeutic Areas & Clinical Trials
  • For Investors
    • Overview
    • News & Events
    • Company Info
    • Financials
    • Stock Data
    • SEC Filings
    • Governance
  • Join Us
    • Values & Culture
    • Explore Careers
  • Contact Us

Governance Documents

View Main Content
For Investors

For Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Info
    • Overview
    • Executive Leadership Team
    • Contacts
    • FAQ
  • Financials
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Whistleblower Policy
  • Governance

  • Overview
  • Board of Directors
  • Board Committees
  • Governance Documents
  • Whistleblower Policy

Code of Business Conduct and Ethics

Download Code of Business Conduct and Ethics

Corporate Governance Guidelines

Download Corporate Governance Guidelines

Whistleblower Policy

Download Whistleblower Policy

Audit Committee Charter

Download Audit Committee Charter

Compensation Committee Charter

Download Compensation Committee Charter

Nominating and Corporate Governance Committee Charter

Download Nominating and Corporate Governance Committee Charter
  • Email Alerts
  • Contacts
  • RSS News Feed
©2025 Immunovant, Inc. All rights reserved.
Privacy Policy Terms of Use Disclaimer Sitemap Manage Cookie Preferences